CHO Pharma, Inc. (6586.TWO)

TWD 42.9

(-17.82%)

Revenue Summary of CHO Pharma, Inc.

  • CHO Pharma, Inc.'s latest annual revenue in 2023 was - TWD , down -100.0% from previous year.
  • CHO Pharma, Inc.'s latest quarterly revenue in 2024 Q2 was 541 Thousand TWD , down 0.0% from previous quarter.
  • CHO Pharma, Inc. reported a annual revenue of 60 Thousand TWD in annual revenue 2022, down -98.32% from previous year.
  • CHO Pharma, Inc. reported a annual revenue of 3.57 Million TWD in annual revenue 2021, up 2486.96% from previous year.
  • CHO Pharma, Inc. reported a quarterly revenue of 541 Thousand TWD for 2024 Q1, down 0.0% from previous quarter.
  • CHO Pharma, Inc. reported a quarterly revenue of - TWD for 2023 Q3, down 0.0% from previous quarter.

Annual Revenue Chart of CHO Pharma, Inc. (2023 - 2019)

Historical Annual Revenue of CHO Pharma, Inc. (2023 - 2019)

Year Revenue Revenue Growth
2023 - TWD -100.0%
2022 60 Thousand TWD -98.32%
2021 3.57 Million TWD 2486.96%
2020 138 Thousand TWD -53.54%
2019 297 Thousand TWD 0.0%

Peer Revenue Comparison of CHO Pharma, Inc.

Name Revenue Revenue Difference
Anti-Microbial Savior BioteQ Co., Ltd 728 Thousand TWD 100.0%
SYN-TECH Chem. & Pharm. Co., Ltd. 1.11 Billion TWD 100.0%
Level Biotechnology Inc. 660.61 Million TWD 100.0%
Sagittarius Life Science Corp 440.46 Million TWD 100.0%
NeoCore Technology Co., Ltd. 64.72 Million TWD 100.0%
TaiMed Biologics Inc. 491.77 Million TWD 100.0%
GlycoNex Incorporation 2.54 Million TWD 100.0%
VBI 55.85 Million TWD 100.0%
GeneReach Biotechnology Corp. 225.46 Million TWD 100.0%
Taiwan Advance Bio-Pharmaceutical Inc. 315.98 Million TWD 100.0%
SynCore Biotechnology Co.,Ltd 20.19 Million TWD 100.0%
Genomics BioSci & Tech. Co.,Ltd. 396.14 Million TWD 100.0%
Visgeneer Inc. 147.99 Million TWD 100.0%
Mycenax Biotech Inc. 652.62 Million TWD 100.0%
Sunmax Biotechnology Co., Ltd. 1.68 Billion TWD 100.0%
G&E Herbal Biotechnology Co., Ltd. 181.44 Million TWD 100.0%
Neith Corporation 39.9 Million TWD 100.0%
Medigen Vaccine Biologics Corporation 389.62 Million TWD 100.0%
TaiwanJ Pharmaceuticals Co., Ltd. 22.74 Million TWD 100.0%
Enimmune corporation 43.49 Million TWD 100.0%
TaiRx, Inc. 5.08 Million TWD 100.0%
EirGenix Inc. 1.02 Billion TWD 100.0%
BioLASCO Taiwan Co., Ltd. 264.72 Million TWD 100.0%
Sunny Pharmtech Inc. 428.82 Million TWD 100.0%
Lin BioScience, Inc. - TWD NaN%
BioGend Therapeutics Co., Ltd. 109.9 Million TWD 100.0%
Feng Chi Biotech Corp. 180.57 Million TWD 100.0%
Bio Preventive Medicine Corp. 1.2 Million TWD 100.0%
Lukas Biomedical Inc. 231.83 Million TWD 100.0%
RBC Bioscience Corporation 172.46 Million TWD 100.0%
BiOptic Inc. 228.26 Million TWD 100.0%
BRIM Biotechnology, Inc. 90 Thousand TWD 100.0%
Shine-On BioMedical Co.,Ltd. 9.52 Million TWD 100.0%
Great Novel Therapeutics Biotech & Medicals 4.85 Million TWD 100.0%
Syngen Biotech Co.,Ltd. 1.83 Billion TWD 100.0%
Advagene Biopharma Co., Ltd. - TWD NaN%
NaviFUS Corp. 22.48 Million TWD 100.0%
Gwo Xi Stem Cell Applied Technology Co. , Ltd 141.17 Million TWD 100.0%
Sinew Pharma Inc. - TWD NaN%
Andros Pharmaceuticals Co.,Ltd 805 Thousand TWD 100.0%
Greenyn Biotechnology Co., Ltd 800.51 Million TWD 100.0%
Lumosa Therapeutics Co., Ltd. 56.91 Million TWD 100.0%
AP Biosciences Inc 32.25 Million TWD 100.0%
Medigen Biotechnology Corp. 1.15 Billion TWD 100.0%
3D Global Biotech Inc. 20.63 Million TWD 100.0%
Pharmosa Biopharm Inc. 314.5 Million TWD 100.0%
Intech Biopharm Corporation 25.84 Million TWD 100.0%
Oneness Biotech Co., Ltd. 86.78 Million TWD 100.0%
Eusol Biotech Co.,Ltd. - TWD NaN%
TWi Biotechnology, Inc. - TWD NaN%
Ever Supreme Bio Technology Co., Ltd 758.39 Million TWD 100.0%
TCI GENE Inc. 333.85 Million TWD 100.0%
MegaPro Biomedical Co., Ltd 18 Thousand TWD 100.0%
Senhwa Biosciences, Inc. 1 Million TWD 100.0%
Taiwan Bio Therapeutics Co., Ltd 85.47 Million TWD 100.0%
NatureWise Biotech & Medicals Corporation 160.14 Million TWD 100.0%
PharmaEngine, Inc. 767.66 Million TWD 100.0%
Savior Lifetec Corporation 1.05 Billion TWD 100.0%
TaiGen Biopharmaceuticals Holdings Limited 123.13 Million TWD 100.0%
OBI Pharma, Inc. 41.54 Million TWD 100.0%
Meribank Biotech Co., Ltd 234.34 Million TWD 100.0%
Acepodia, Inc. 16.59 Million TWD 100.0%
Caliway Biopharmaceuticals Co., Ltd. 38.93 Million TWD 100.0%